These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3736728)

  • 21. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
    Saletu B; Saletu M; Itil T; Marasa J
    Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
    Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
    Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS; Brown WA; Laughren TP; Krantz J
    Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
    [No Abstract]   [Full Text] [Related]  

  • 25. To the incompatibility of haloperidol with lithium salts.
    Marhold J; Zimanová J; Lachman M; Král J; Vojtĕchovský M
    Act Nerv Super (Praha); 1974 Aug; 16(3):199-200. PubMed ID: 4420744
    [No Abstract]   [Full Text] [Related]  

  • 26. Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients.
    Schulz SC; Thompson PA; Jacobs M; Ninan PT; Robinson D; Weiden PJ; Yadalam K; Glick ID; Odbert CL
    J Clin Psychiatry; 1999 Jun; 60(6):366-72. PubMed ID: 10401914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sleep in Huntington chorea: its modification following lithium carbonate and lithium carbonate-haloperidol therapy].
    Puca F; Specchio LM; Genco S; Internò S; Castriotta R
    Riv Neurol; 1978; 48(6):708-16. PubMed ID: 154167
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychosocial profiles and efficacy of lithium treatment.
    Demers RG
    Dis Nerv Syst; 1971 Apr; 32(4):249-54. PubMed ID: 5089991
    [No Abstract]   [Full Text] [Related]  

  • 30. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
    Lee BJ; Lee JG; Kim YH
    J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Complications of combined use of lithium salts and neuroleptics in patients with endogenous psychoses].
    Mosolov SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):115-21. PubMed ID: 6134409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
    Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
    Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
    Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuroleptic treatment and neurological soft signs in schizophrenic patients].
    Mechri A; Slama H; Chebel S; Mandhouj O; Gaha L
    Therapie; 2007; 62(5):449-53. PubMed ID: 18206107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of haloperidol on serum levels of lithium in adult manic patients.
    Schaffer CB; Batra K; Garvey MJ; Mungas DM; Schaffer LC
    Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia].
    Kadysheva NM; Mokhovikov AN; Mosketi KV; Kryzhanovskiĭ GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(10):88-92. PubMed ID: 2975124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of pinpointing mood swings in expanding the indications for lithium salts in schizophrenic psychosis].
    Capdeville C; Darcourt G
    Ann Med Psychol (Paris); 1987 Jan; 145(1):78-82. PubMed ID: 2886087
    [No Abstract]   [Full Text] [Related]  

  • 40. Antipsychotic effect of cannabidiol.
    Zuardi AW; Morais SL; Guimarães FS; Mechoulam R
    J Clin Psychiatry; 1995 Oct; 56(10):485-6. PubMed ID: 7559378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.